The novel coronavirus SARS-CoV-2 (COVID-19) pandemic has created diagnostic uncertainty with regards to distinguishing this infection from pulmonary embolism (PE). Although there appears to be an increased incidence of thromboembolic disease in patients with COVID-19 infection, recommendations regarding anticoagulation are lacking. We present the case of a 61-year-old woman with clinically significant venous and arterial thromboemboli in the setting of COVID-19 infection requiring tissue plasminogen activator (tPA).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248631 | PMC |
| http://dx.doi.org/10.1016/j.ajem.2020.05.054 | DOI Listing |
Publication Analysis
Top Keywords
covid-19 infection
12
abdominal pain
4
pain patient
4
covid-19
4
patient covid-19
4
infection
4
infection case
4
case multiple
4
multiple thromboemboli
4
thromboemboli novel
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!